The global Myomectomy market is projected to reach USD 1,207.5 Million by 2028, growing at a CAGR of 9.7%. Increasing number of patients suffering from uterine fibroids and related disorders, rising acceptance of technologically innovative devices for safe and effective Myomectomy processes and mounting number of minimally invasive techniques are some of the factors driving the growth of the global Myomectomy market.
Adroit Market Research report on global Myomectomy market gives a holistic view of the market from 2018 to 2028, which includes factors such as market drivers, restraints, opportunities and challenges. The market has been studied for historic years from 2018 to 2019, with the base year of estimation as 2020 and forecast from 2021 to 2028. The report covers the current status and future traits of the market at global as well as country level. In addition, the study also assesses the key players based on their product portfolio, geographic footprint, strategic initiatives and overall revenue. Prominent players operating in the global Myomectomy market have been studied in detail.
Myomectomy encompasses removal of one or more uterine fibroids from the uterus and reparation of the flaw in the wall of the uterus formed by eliminating the fibroid. The procedure can be executed in a number of ways, contingent on the location, size, and number of fibroids existent.
The global Myomectomy market is categorized based on type and product. On the basis of type, the market is segmented into abdominal, laparoscopic and hysteroscopic Myomectomy. The abdominal Myomectomy segment led the market in 2020 as it is a commonly wished treatment for fibroids. The laparoscopic Myomectomy segment is anticipated to observer the highest CAGR over the forecast period.
North America dominated the market for Myomectomy in 2020, while Asia Pacific is set to grow at a highest CAGR due to increase in cognizance concerning disease diagnosis and treatment. Key players of the global Myomectomy market include Medtronic, CONMED Corporation, Stryker Corporation, CooperSurgical Inc., Hologic, Inc., Ethicon, Inc., Minerva Surgical, Inc., Karl Storz GmbH, INSIGHTEC, Intuitive Surgical among others.
Key segments of the global Myomectomy market
Type Overview, 2018-2028 (USD Million)
- Abdominal Myomectomy
- Hysteroscopic Myomectomy
- Laparoscopic Myomectomy
Product Overview, 2018-2028 (USD Million)
- Laparoscopic Power Morcellators
- Harmonic Scalpel
- Laparoscopic Sealer
Regional Overview, 2018-2028 (USD Million)
- North America
- United Kingdom
- Asia Pacific
- Latin America
- Middle East & Africa
- South Africa